SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+13.59%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$328M
AUM Growth
+$328M
(+26%)
Cap. Flow
+$43.7M
Cap. Flow
% of AUM
13.33%
Top 10 Holdings %
Top 10 Hldgs %
41.01%
Holding
89
New
15
Increased
27
Reduced
12
Closed
21
Top Buys
| 1 |
Biogen
BIIB
|
$18.6M |
| 2 |
CVS Health
CVS
|
$12M |
| 3 |
GSK
GSK
|
$10.9M |
| 4 |
Ascendis Pharma
ASND
|
$10.6M |
| 5 |
Globus Medical
GMED
|
$10M |
Top Sells
| 1 |
Cencora
COR
|
$9.97M |
| 2 |
Cigna
CI
|
$9.92M |
| 3 |
Cardinal Health
CAH
|
$9.32M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.05M |
| 5 |
CELG
Celgene Corp
CELG
|
$6.56M |
Sector Composition
| 1 | Healthcare | 90.58% |
| 2 | Industrials | 1.25% |
| 3 | Technology | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CVS Health
CVS
$92.8B
| $19.8M | 5.34% | 367,071 +222,294 | +154% | +$12M |
|
|
2
Biogen
BIIB
$19.4B
| $18.6M | 5.02% | +78,596 | New | +$18.6M |
|
3
Gilead Sciences
GILD
$140B
| $16M | 4.32% | 245,968 +149,488 | +155% | +$9.72M |
|
4
HCA Healthcare
HCA
$94.5B
| $14M | 3.78% | 107,428 +39,389 | +58% | +$5.14M |
|
5
Medtronic
MDT
$119B
| $12M | 3.23% | 131,464 +349 | +0.3% | +$31.8K |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.2M | 3.03% | 766,980 +323,571 | +73% | +$4.74M |
|
|
7
GSK
GSK
$79.9B
| $10.9M | 2.96% | +262,000 | New | +$10.9M |
|
8
Medpace
MEDP
$13.4B
| $10.7M | 2.9% | 181,866 +118,686 | +188% | +$7M |
|
|
9
Ascendis Pharma
ASND
$11.8B
| $10.6M | 2.87% | +90,325 | New | +$10.6M |
|
|
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $10.5M | 2.83% | 62,186 -22,000 | -26% | -$3.71M |
|
|
11
Globus Medical
GMED
$8.27B
| $10M | 2.71% | +202,827 | New | +$10M |
|
12
Emergent Biosolutions
EBS
$443M
| $9.1M | 2.46% | 180,156 +106,363 | +144% | +$5.37M |
|
13
Novo Nordisk
NVO
$251B
| $8.47M | 2.29% | 162,000 +14,622 | +10% | +$765K |
|
14
Viking Therapeutics
VKTX
$3.04B
| $8.47M | 2.29% | 852,160 +215,114 | +34% | +$2.14M |
|
|
15
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.4M | 2% | 79,153 -75,484 | -49% | -$7.05M |
|
|
CCXI
16
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.36M | 1.99% | 530,175 +360,918 | +213% | +$5.01M |
|
17
MEI Pharma
MEIP
$160M
| $7.24M | 1.95% | 2,356,633 -17,208 | -0.7% | -$52.8K |
|
18
Sanofi
SNY
$121B
| $6.95M | 1.88% | 156,854 -111,534 | -42% | -$4.94M |
|
19
Molina Healthcare
MOH
$9.8B
| $6.38M | 1.72% | 44,928 +2,059 | +5% | +$292K |
|
20
McKesson
MCK
$85.4B
| $6.01M | 1.62% | 51,300 +4,770 | +10% | +$558K |
|
|
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.92M | 1.6% | +554,019 | New | +$5.92M |
|
|
WCG
22
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.79M | 1.56% | +21,459 | New | +$5.79M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $5.19M | 1.4% | +28,232 | New | +$5.19M |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.86M | 1.31% | 1,295,669 +144,159 | +13% | +$541K |
|
|
ALXN
25
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.79M | 1.29% | 35,421 +18,421 | +108% | +$2.49M |
|